News
President Trump wants to bring manufacturing back to the U.S. These companies say they're investing in domestic factories.
The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry ...
The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...
Levies on Americans’ daily prescriptions and other medicines could raise costs, spur rationing and lead to shortages of ...
The Trump administration on Monday took a step toward enacting its aims to tariff pharmaceutical imports, disclosing plans to ...
What Johnson & Johnson and Eli Lilly are saying about Trump’s pharmaceutical tariffs, and Dexcom scores FDA approval for its ...
President Donald Trump's administration took new steps toward imposing tariffs on imported semiconductors and pharmaceutical products Monday.
The president's tariffs went into effect Wednesday at 12:01 a.m. amid stock market woes and negotiations with trading partners.
Explore the impact of proposed Pharma tariffs on global markets as major stocks tumble. Click for my updated look at selected picks in the health industry.
A Section 232 investigation, enabled by the Trade Expansion Act of 1962, looks into the effects ... months, Trump has threatened 25% or higher tariffs on pharmaceuticals as well. Pharma companies ...
The Commerce Department has begun a so-called Section 232 investigation into the national security effects of the U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results